Archer Materials Develops initial biochip component
- Archer Materials (AXE) progresses early-stage assembly of components for its biochip which is being developed to detect communicable diseases
- The company’s ‘lab-on-a-chip’ technology is being designed to allow analysis of tiny amounts of liquid or gas samples such as saliva, blood and breath
- Current work is focused on strengthening and expanding nano and micro-fabrication capabilities, which AXE says presents a challenge to commercialising the biochip devices
- Archer has miniaturised microfluidic channels, marking a step towards developing an aspect of the device needed for future operation of the biochip
- Shares have been trading 5.6 per cent higher at $1.69
